Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Products>This Product
  Products


FlowSyn™ Maxi from Uniqsis – Scaling up your flow chemistry experiments has never been easier!

Product Image
Product Description

Increase your productivity to 5 kg+ per day with the FlowSyn™ Maxi from Uniqsis!

CPSU_FP_01102013a.gifNow available with a Hastelloy® flowpath for ultimate chemical compatibility, the FlowSyn Maxi is a versatile and highly productive continuous flow reactor for high-throughput single reactions with two reagents.

This highly robust system is capable of operating at 260°C, at a maximum pressure up to 200 bar, and withstanding contact with corrosive fluids such as sulphuric and nitric acid. With a flow rate of up to 80 ml/ min and the option to use Uniqsis’ high capacity (60 ml) coil reactor, it is the ideal scale-up tool for increasing your output to multi kg per day.

With Uniqsis’ intuitive and highly flexible FlowControl software you can program and automate sequences of flow chemistry experiments with an unprecedented degree of freedom. Simply start with the molarity and number of equivalents of each reagent required and then define the reactor temperatures and residence times.

The user interface quickly guides you through the process of setting up your desired flow chemistry reactions, and the system then automatically runs the experiment, finishing with a self-cleaning routine at the end of the program cycle. Comprehensive safety features, including automatic pressure regulation and over-pressure shut-down, ensure safe operation at all times.

Uniqsis offers extensive “plug and play” options for temperature controlled static mixers and coil reactors, including the FlowSyn 60 ml coil reactor kit specifically designed for scale-up.

CPSU_FP_01102013b.gifThe FlowSyn Maxi can be expanded with the Uniqsis Binary Pump Module (BPM) to provide four reagent inputs and with other FlowSyn modules for automated multi-experiment and multi-step combinatorial capability. Optional cooling modules, with cooling capacities down to -88°C, are available for controlling highly exothermic reactions.

If you are looking at improving the output of your flow chemistry experiments, consider the FlowSyn Maxi from Uniqsis. Scale-up has never been easier!

Product FlowSyn™ Maxi from Uniqsis – Scaling up your flow chemistry experiments has never been easier!
Company Uniqsis
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Uniqsis
29 Station Road Shepreth Cambridgeshire SG8 6GB UK

Tel: +44 (0)845 864 7747

Email: info@uniqsis.com



Scientific News
NIH Study Finds Calorie Restriction Lowers Some Risk Factors for Age-Related Diseases
Two-year trial did not produce expected metabolic changes, but influenced other life span markers.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Low-level Arsenic Exposure Before Birth Associated with Early Puberty in Female Mice
Study examine whether low-dose arsenic exposure could have similar health outcomes in humans.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Cellular Contamination Pathway for Heavy Elements Identified
Berkeley Lab scientists find that an iron-binding protein can transport actinides into cells.
Intensity of Desert Storms May Affect Ocean Phytoplankton
MIT study finds phytoplankton are extremely sensitive to changing levels of desert dust.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Scroll Up
Scroll Down

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!